ID: ALA73311

Max Phase: Preclinical

Molecular Formula: C18H16N2O2

Molecular Weight: 292.34

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(c1ccc(O)cc1)N1CCc2c([nH]c3ccccc23)C1

Standard InChI:  InChI=1S/C18H16N2O2/c21-13-7-5-12(6-8-13)18(22)20-10-9-15-14-3-1-2-4-16(14)19-17(15)11-20/h1-8,19,21H,9-11H2

Standard InChI Key:  KEBXFLCCYVJERH-UHFFFAOYSA-N

Associated Targets(non-human)

Enoyl-[acyl-carrier-protein] reductase 206 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 292.34Molecular Weight (Monoisotopic): 292.1212AlogP: 3.07#Rotatable Bonds: 1
Polar Surface Area: 56.33Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.46CX Basic pKa: CX LogP: 2.75CX LogD: 2.71
Aromatic Rings: 3Heavy Atoms: 22QED Weighted: 0.72Np Likeness Score: -0.63

References

1. Seefeld MA, Miller WH, Newlander KA, Burgess WJ, Payne DJ, Rittenhouse SF, Moore TD, DeWolf WE, Keller PM, Qiu X, Janson CA, Vaidya K, Fosberry AP, Smyth MG, Jaworski DD, Slater-Radosti C, Huffman WF..  (2001)  Inhibitors of bacterial enoyl acyl carrier protein reductase (FabI): 2,9-disubstituted 1,2,3,4-tetrahydropyrido[3,4-b]indoles as potential antibacterial agents.,  11  (17): [PMID:11527706] [10.1016/s0960-894x(01)00405-x]

Source